Evidence40%Reported
OpinionBusiness·April 7, 2026
Simply Wall St: UK Boycott, Maven, and NHS Deals Reshape Palantir Outlook
Simply Wall St analysis highlights that Palantir's deepening partnerships with Stellantis, Bain & Company, and Maven program-of-record status contrast with UK NHS boycott pressures, creating a core tension between growth wins and reputational/regulatory risk in European markets.
Evidence Strength
Evidence40%Reported
Based on original reporting
Single publisher source
Insights
First tracked
April 7, 2026
Last updated
April 7, 2026
Sources
1 source
Related Developments
Stellantis Renews and Expands Partnership with PalantirMichael Burry Maintains $1.1B Short Position Against Palantir Despite Trump Endorsement, Says Stock Worth 'Well Under $50'Army Issues RFI for Automated Target Recognition Algorithms and Sensors for Explosive Hazard DetectionUK Regulatory and Ethical Scrutiny of Palantir's Public Health and Defense OperationsSimply Wall St: Anthropic's Enterprise AI Push Pressures Palantir's Premium Positioning and Moat
Sources (1)
Source Timeline
Evidence Strength
Evidence40%Reported
Based on original reporting
Single publisher source
Insights
First tracked
April 7, 2026
Last updated
April 7, 2026
Sources
1 source
Related Developments
Stellantis Renews and Expands Partnership with PalantirMichael Burry Maintains $1.1B Short Position Against Palantir Despite Trump Endorsement, Says Stock Worth 'Well Under $50'Army Issues RFI for Automated Target Recognition Algorithms and Sensors for Explosive Hazard DetectionUK Regulatory and Ethical Scrutiny of Palantir's Public Health and Defense OperationsSimply Wall St: Anthropic's Enterprise AI Push Pressures Palantir's Premium Positioning and Moat